About this trial
Clinical Study to Assess the Safety and Efficacy of CS-002 (mTOR inhibitor) as a treatment for Canities (Grey Hair)
Eligibility criteria
Qualifiers
Age 30 to 65
Diagnosed with Grey Hair (Canities)
Willing and able to apply the treatment as directed, comply with study
Otherwise healthy
Disqualifiers
A medical history that may interfere with study objectives
Women who are pregnant, lactating, or planning to become pregnant during the study period
Subjects who have experienced a clinically important medical event within 90 days of the visit (e.g., stroke, myocardial infarction, etc)
Subjects who have known allergies to any excipient in CS-001
Trial design
Treatments tested in this trial
- CS-002
- Placebo Topical Solution
Treatment groups
100 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Applied Biology, Inc.
Lead sponsor
Complex Science
Collaborator
Source ClinicalTrials.gov